By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Topical antipsoriatics > Betamethasone and calcipotriene topical > Betamethasone / Calcipotriene Topical Dosage
Topical antipsoriatics
https://themeditary.com/dosage-information/betamethasone-calcipotriene-topical-dosage-6528.html

Betamethasone / Calcipotriene Topical Dosage

Drug Detail:Betamethasone and calcipotriene topical (Betamethasone and calcipotriene topical [ bay-ta-meth-a-sone-and-kal-si-poe-trye-een ])

Drug Class: Topical antipsoriatics

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Psoriasis

OINTMENT:

  • Apply to the affected area(s) once a day for up to 4 weeks; rub in gently and completely
  • The maximum weekly dose should not exceed 100 g.
  • Treatment of more than 30% body surface area is not recommended.
  • Discontinue therapy when control is achieved.
  • Do not use with occlusive dressings unless directed by a physician.
  • Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.

TOPICAL SUSPENSION:
  • Apply to affected area(s) once daily for up to 8 weeks.
  • The maximum weekly dose should not exceed 100 g.
  • Treatment of more than 30% body surface area is not recommended.
  • Discontinue therapy when control is achieved.
  • Do not use with occlusive dressings unless directed by a physician.
  • Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.

FOAM AEROSOL:
  • Apply to affected area(s) once daily for up to 4 weeks; rub in gently and completely
  • Do not use more than 60 g every 4 days.
  • Discontinue therapy when control is achieved.
  • Do not use with occlusive dressings unless directed by a physician.
  • Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.

Uses:
  • Ointment formulation: For the topical treatment of plaque psoriasis in patients 12 years of age and older
  • Topical suspension: For plaque psoriasis of the scalp and body in patients 18 years and older
  • Foam aerosol: For the topical treatment of plaque psoriasis in patients 18 years of age and older

Usual Pediatric Dose for Psoriasis

OINTMENT:
12 years and older:

  • Apply to the affected area(s) once a day for up to 4 weeks; rub in gently and completely
  • The maximum weekly dose should not exceed 60 g.
  • Treatment of more than 30% body surface area is not recommended.
  • Discontinue therapy when control is achieved.
  • Do not use with occlusive dressings unless directed by a physician.
  • Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.

TOPICAL SUSPENSION:
12 years and older:
  • Apply to affected area(s) once daily for up to 8 weeks.
  • The maximum weekly dose should not exceed 60 g.
  • Treatment of more than 30% body surface area is not recommended.
  • Discontinue therapy when control is achieved.
  • Do not use with occlusive dressings unless directed by a physician.
  • Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.

FOAM AEROSOL:
12 years and older:
  • Apply to affected area(s) once daily for up to 4 weeks; rub in gently and completely
  • Do not use more than 60 g every 4 days.
  • Discontinue therapy when control is achieved.
  • Do not use with occlusive dressings unless directed by a physician.
  • Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.

Uses:
  • Ointment and foam formulations: For the topical treatment of plaque psoriasis in patients 12 years of age and older
  • Topical suspension: For plaque psoriasis of the scalp in patients 12 to 17 years

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:

  • None

Safety and efficacy have not been established in patients younger than 12 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Rub product in gently and completely.
  • Patients should wash their hands after application of the product.
  • Avoid excessive exposure to either natural or artificial sunlight. Physicians may wish to limit or avoid use of phototherapy in such patients.
  • Do not use this drug combination orally, ophthalmically, or intravaginally.
  • Instruct patients to shake bottle prior to using the topical suspension or foam.

General:
This topical drug combination may cause eye irritation. Eye exposure should be avoided.

Frequently asked questions

  • Can Enstilar be used on the scalp?
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by